These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 36647985

  • 1. Outcomes of Different Immunosuppressive Regimen in Adult Biopsy Proven Idiopathic Focal Segmental Glomerulosclerosis: A Retrospective Analysis at a Single Center.
    Qureshi R, Nasir K, Imtiaz S, Dhrolia MF, Ahmad A, Salman B.
    Saudi J Kidney Dis Transpl; 2022; 33(1):111-121. PubMed ID: 36647985
    [Abstract] [Full Text] [Related]

  • 2. Idiopathic nephrotic syndrome in Syrian children: clinicopathological spectrum, treatment, and outcomes.
    Wannous H.
    Pediatr Nephrol; 2024 Aug; 39(8):2413-2422. PubMed ID: 38587559
    [Abstract] [Full Text] [Related]

  • 3. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome.
    Gellermann J, Ehrich JH, Querfeld U.
    Nephrol Dial Transplant; 2012 May; 27(5):1970-8. PubMed ID: 21976740
    [Abstract] [Full Text] [Related]

  • 4. Steroid resistant focal segmental glomerulosclerosis: effect of arterial hyalinosis on outcome: single center study.
    Soliman AR, Maamoun H, Soliman H, Ahmed RM.
    Rom J Intern Med; 2021 Jun 01; 59(2):127-133. PubMed ID: 33565308
    [Abstract] [Full Text] [Related]

  • 5. Combination of immunosuppressive agents in treatment of steroid-resistant minimal change disease and primary focal segmental glomerulosclerosis.
    El-Reshaid K, El-Reshaid W, Madda J.
    Ren Fail; 2005 Jun 01; 27(5):523-30. PubMed ID: 16152989
    [Abstract] [Full Text] [Related]

  • 6. Frequently relapsing nephrotic syndrome: treatment with mycophenolate mofetil.
    Gellermann J, Querfeld U.
    Pediatr Nephrol; 2004 Jan 01; 19(1):101-4. PubMed ID: 14753204
    [Abstract] [Full Text] [Related]

  • 7. A prospective study of collapsing focal segmental glomerulosclerosis.
    Raja R, Nada R, Yadav AK, Kumar A, Goyal A, Kumar V, Rathi M, Kohli HS, Gupta KL, Sakhuja V, Jha V.
    Ren Fail; 2016 Jul 01; 38(6):894-8. PubMed ID: 27266801
    [Abstract] [Full Text] [Related]

  • 8. Mycophenolate mofetil or standard therapy for membranous nephropathy and focal segmental glomerulosclerosis: a pilot study.
    Senthil Nayagam L, Ganguli A, Rathi M, Kohli HS, Gupta KL, Joshi K, Sakhuja V, Jha V.
    Nephrol Dial Transplant; 2008 Jun 01; 23(6):1926-30. PubMed ID: 17989103
    [Abstract] [Full Text] [Related]

  • 9. Clinical Course and Long-term Outcome of Adults with Primary Focal Segmental Glomerulosclerosis: A Retrospective Cohort Study.
    Jafry N, Mubarak M, Rauf A, Rasheed F, Ahmed E.
    Iran J Kidney Dis; 2022 May 01; 16(3):195-202. PubMed ID: 35714214
    [Abstract] [Full Text] [Related]

  • 10. Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndrome.
    Mendizábal S, Zamora I, Berbel O, Sanahuja MJ, Fuentes J, Simon J.
    Pediatr Nephrol; 2005 Jul 01; 20(7):914-9. PubMed ID: 15891923
    [Abstract] [Full Text] [Related]

  • 11. Outcomes of primary nephrotic syndrome in elderly Japanese: retrospective analysis of the Japan Renal Biopsy Registry (J-RBR).
    Yokoyama H, Sugiyama H, Narita I, Saito T, Yamagata K, Nishio S, Fujimoto S, Mori N, Yuzawa Y, Okuda S, Maruyama S, Sato H, Ueda Y, Makino H, Matsuo S.
    Clin Exp Nephrol; 2015 Jun 01; 19(3):496-505. PubMed ID: 25230687
    [Abstract] [Full Text] [Related]

  • 12. Mycophenolate mofetil and prednisolone therapy in children with steroid-dependent nephrotic syndrome.
    Bagga A, Hari P, Moudgil A, Jordan SC.
    Am J Kidney Dis; 2003 Dec 01; 42(6):1114-20. PubMed ID: 14655181
    [Abstract] [Full Text] [Related]

  • 13. Mycophenolate mofetil in the treatment of steroid-resistant primary focal segmental glomerulosclerosis.
    Tang S, Ho YW, Leung CY, Lai KN.
    J Nephrol; 2005 Dec 01; 18(4):429-32. PubMed ID: 16245248
    [Abstract] [Full Text] [Related]

  • 14. Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants.
    Chun MJ, Korbet SM, Schwartz MM, Lewis EJ.
    J Am Soc Nephrol; 2004 Aug 01; 15(8):2169-77. PubMed ID: 15284302
    [Abstract] [Full Text] [Related]

  • 15. Cyclosporine-based immunosuppressive therapy for patients with steroid-resistant focal segmental glomerulosclerosis: a meta-analysis.
    Chiou YY, Lee YC, Chen MJ.
    Curr Med Res Opin; 2017 Aug 01; 33(8):1389-1399. PubMed ID: 28436233
    [Abstract] [Full Text] [Related]

  • 16. Other immunosuppressive agents for focal segmental glomerulosclerosis.
    Ponticelli C, Passerini P.
    Semin Nephrol; 2003 Mar 01; 23(2):242-8. PubMed ID: 12704585
    [Abstract] [Full Text] [Related]

  • 17. Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.
    Li X, Li H, Ye H, Li Q, He X, Zhang X, Chen Y, Han F, He Q, Wang H, Chen J.
    Am J Kidney Dis; 2009 Jul 01; 54(1):51-8. PubMed ID: 19406543
    [Abstract] [Full Text] [Related]

  • 18. Long-term outcome of idiopathic steroid-resistant nephrotic syndrome in children.
    Inaba A, Hamasaki Y, Ishikura K, Hamada R, Sakai T, Hataya H, Komaki F, Kaneko T, Mori M, Honda M.
    Pediatr Nephrol; 2016 Mar 01; 31(3):425-34. PubMed ID: 26335197
    [Abstract] [Full Text] [Related]

  • 19. Fifteen-year remission of a steroid-resistant nephrotic syndrome sustained by cyclosporine A.
    Drube J, Geerlings C, Taylor R, Mengel M, Ehrich JH.
    Pediatr Nephrol; 2007 Apr 01; 22(4):600-2. PubMed ID: 17235550
    [Abstract] [Full Text] [Related]

  • 20. The efficacy of cyclosporine A in adult nephrotic syndrome with minimal change disease and focal-segmental glomerulosclerosis: a multicenter study in Korea.
    Lee HY, Kim HS, Kang CM, Kim SG, Kim MJ.
    Clin Nephrol; 1995 Jun 01; 43(6):375-81. PubMed ID: 7554521
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.